(Correction) Partially Corrected Financial Summary for the 42nd Term Full-Year Financial Results

Performance Overview

The consolidated earnings forecast for the fiscal year ending March 2027 projects revenue of 81.8 billion yen (up 14.0% YoY), operating profit of 8.2 billion yen (up 5.7% YoY), and net income attributable to owners of the parent of 5.38 billion yen (up 3.9% YoY). The operating profit margin is expected to be 10.0%, a decrease of 0.8 points compared to the same period last year. Driven by the information infrastructure business and excluding the impact of the consolidation of Medmain Inc., a medical systems subsidiary, the results are expected to be in line with plans.

Segment Performance Outlook

The information infrastructure segment is expected to achieve revenue of 59.5 billion yen (up 15.3% YoY) and operating profit of 7.24 billion yen (up 10.0% YoY), reflecting steady growth. The Application & SaaS segment is forecasted to have revenue of 11.13 billion yen (up 12.6% YoY), but operating profit is expected to decline by 289 million yen. The medical systems segment is projected to generate revenue of 11.17 billion yen (up 9.2% YoY), but operating profit is expected to decrease by 42.8% YoY to 760 million yen.